Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuling Zhou

Showing results (21-30 of 223) with videos related to

Pageof 23
Sort By:
Cellular Oncology (Dordrecht, Netherlands)|September 22, 2018
Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell deathKashif Rafiq Zahid, Shiming Han, Fuling Zhou, et al.
Frontiers in Pharmacology|March 15, 2018
Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human CancerGuohong Liu, Francois X Claret, Fuling Zhou, et al.
Blood Reviews|September 24, 2013
Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic interventionFuling Zhou, Shan Meng, Huanjin Song, et al.
Clinical and Experimental Medicine|July 29, 2017
DNA methylation profiles in cancer diagnosis and therapeuticsYunbao Pan, Guohong Liu, Fuling Zhou, et al.
Journal of Medical Virology|December 8, 2020
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19Yufeng Shang, Tao Liu, Jingfeng Li, et al.
Biomarker Research|December 9, 2020
The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applicationsNatasha Mupeta Kaweme, Shu Zhou, Geoffrey Joseph Changwe, et al.
Therapeutic Advances in Hematology|May 24, 2023
Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDSXiaoyan Lv, Pengpeng Li, Pengpeng Yue, et al.
Leukemia & Lymphoma|May 14, 2020
Wilms' tumor 1 gene in hematopoietic malignancies: clinical implications and future directionsPing Luo, Wei Jing, Kezhen Yi, et al.
BMC Cancer|July 31, 2023
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancersQing Tan, Qian Wang, Suoqin Jin, et al.
Journal of Medical Virology|December 1, 2021
Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patientsYufeng Shang, Yuxing Liang, Tao Liu, et al.
Pageof 23

Showing results (21-30 of 223) with videos related to

Sort By:
Pageof 23
Cellular Oncology (Dordrecht, Netherlands)|September 22, 2018
Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell deathKashif Rafiq Zahid, Shiming Han, Fuling Zhou, et al.
Frontiers in Pharmacology|March 15, 2018
Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human CancerGuohong Liu, Francois X Claret, Fuling Zhou, et al.
Blood Reviews|September 24, 2013
Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic interventionFuling Zhou, Shan Meng, Huanjin Song, et al.
Clinical and Experimental Medicine|July 29, 2017
DNA methylation profiles in cancer diagnosis and therapeuticsYunbao Pan, Guohong Liu, Fuling Zhou, et al.
Journal of Medical Virology|December 8, 2020
Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19Yufeng Shang, Tao Liu, Jingfeng Li, et al.
Biomarker Research|December 9, 2020
The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applicationsNatasha Mupeta Kaweme, Shu Zhou, Geoffrey Joseph Changwe, et al.
Therapeutic Advances in Hematology|May 24, 2023
Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDSXiaoyan Lv, Pengpeng Li, Pengpeng Yue, et al.
Leukemia & Lymphoma|May 14, 2020
Wilms' tumor 1 gene in hematopoietic malignancies: clinical implications and future directionsPing Luo, Wei Jing, Kezhen Yi, et al.
BMC Cancer|July 31, 2023
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancersQing Tan, Qian Wang, Suoqin Jin, et al.
Journal of Medical Virology|December 1, 2021
Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patientsYufeng Shang, Yuxing Liang, Tao Liu, et al.
Pageof 23